HEADER PROTEIN FIBRIL 21-NOV-16 5MGQ TITLE SOLUTION STRUCTURE OF OXIDIZED AND AMIDATED HUMAN IAPP (1-37), THE TITLE 2 DIABETES II PEPTIDE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: ISLET AMYLOID POLYPEPTIDE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: AMYLIN,DIABETES-ASSOCIATED PEPTIDE,DAP,INSULINOMA AMYLOID COMPND 5 PEPTIDE; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: RESIDUE NAME "TYC" REFERS TO AMIDATION OF C-TERMINAL COMPND 8 TYR. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IAPP; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS RECOMBINANT HUMAN IAPP, TYPE II DIABETES, PROTEIN FIBRIL EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR D.C.RODRIGUEZ CAMARGO,K.TRIPSIANES,B.REIF REVDAT 5 14-JUN-23 5MGQ 1 REMARK SEQRES REVDAT 4 08-MAY-19 5MGQ 1 REMARK REVDAT 3 17-JAN-18 5MGQ 1 COMPND REVDAT 2 06-SEP-17 5MGQ 1 REMARK REVDAT 1 29-MAR-17 5MGQ 0 JRNL AUTH D.C.RODRIGUEZ CAMARGO,K.TRIPSIANES,K.BUDAY,A.FRANKO,C.GOBL, JRNL AUTH 2 C.HARTLMULLER,R.SARKAR,M.AICHLER,G.METTENLEITER,M.SCHULZ, JRNL AUTH 3 A.BODDRICH,C.ERCK,H.MARTENS,A.K.WALCH,T.MADL,E.E.WANKER, JRNL AUTH 4 M.CONRAD,M.H.DE ANGELIS,B.REIF JRNL TITL THE REDOX ENVIRONMENT TRIGGERS CONFORMATIONAL CHANGES AND JRNL TITL 2 AGGREGATION OF HIAPP IN TYPE II DIABETES. JRNL REF SCI REP V. 7 44041 2017 JRNL REFN ESSN 2045-2322 JRNL PMID 28287098 JRNL DOI 10.1038/SREP44041 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER A. T. ET.AL. REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5MGQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-NOV-16. REMARK 100 THE DEPOSITION ID IS D_1200002414. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 278 REMARK 210 PH : 5.3 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 150 UM [U-99% 13C; U-99% 15N] REMARK 210 ISLET AMYLOID POLYPEPTIDE (IAPP REMARK 210 OR AMYLIN), 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 3D HNCACB; 3D CBCA(CO)NH; 3D REMARK 210 HCCH-TOCSY; 3D 1H-15N NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ; 750 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : SPARKY, TOPSPIN, CYANA REMARK 210 METHOD USED : MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 200 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 3260 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASN A 3 20.80 -147.50 REMARK 500 1 HIS A 18 -38.60 -143.89 REMARK 500 1 ASN A 22 -35.15 -138.17 REMARK 500 1 PHE A 23 88.59 -45.16 REMARK 500 1 SER A 29 -30.23 67.77 REMARK 500 1 SER A 34 73.40 55.38 REMARK 500 2 SER A 29 -13.44 72.86 REMARK 500 3 PHE A 23 96.61 -53.82 REMARK 500 4 SER A 29 -10.63 68.44 REMARK 500 5 HIS A 18 15.22 -142.51 REMARK 500 5 SER A 20 6.62 -65.98 REMARK 500 5 ASN A 22 -33.88 -139.47 REMARK 500 5 PHE A 23 93.08 -47.75 REMARK 500 5 THR A 30 0.42 54.44 REMARK 500 6 ASN A 3 18.37 -144.75 REMARK 500 6 CYS A 7 -38.49 -133.14 REMARK 500 6 ASN A 22 -39.02 -136.85 REMARK 500 6 PHE A 23 102.05 -56.94 REMARK 500 6 ASN A 35 90.39 59.26 REMARK 500 7 ASN A 3 20.26 -140.57 REMARK 500 7 HIS A 18 -51.74 -139.99 REMARK 500 7 SER A 29 -33.72 66.08 REMARK 500 7 THR A 30 29.55 -74.65 REMARK 500 8 CYS A 7 -39.15 -130.34 REMARK 500 8 ASN A 22 -36.25 -134.36 REMARK 500 8 PHE A 23 99.50 -55.14 REMARK 500 8 ASN A 35 130.00 -171.46 REMARK 500 9 HIS A 18 29.24 -158.59 REMARK 500 9 ASN A 22 -36.67 -132.66 REMARK 500 9 PHE A 23 83.65 -48.91 REMARK 500 10 ASN A 3 25.33 -154.27 REMARK 500 10 CYS A 7 -39.28 -130.64 REMARK 500 10 HIS A 18 16.69 -159.12 REMARK 500 10 SER A 20 12.19 -65.35 REMARK 500 10 ASN A 22 -38.48 -137.81 REMARK 500 10 PHE A 23 93.12 -47.52 REMARK 500 10 ASN A 31 39.56 -140.31 REMARK 500 11 SER A 20 1.94 -68.35 REMARK 500 11 ASN A 22 -50.63 -128.75 REMARK 500 11 PHE A 23 93.45 -54.13 REMARK 500 11 ASN A 35 -34.95 -146.72 REMARK 500 12 ASN A 3 21.71 -145.90 REMARK 500 12 SER A 20 -7.41 -56.48 REMARK 500 12 ASN A 22 -39.96 -133.91 REMARK 500 12 PHE A 23 102.58 -51.22 REMARK 500 13 ASN A 3 18.21 -144.36 REMARK 500 13 CYS A 7 -43.37 -131.19 REMARK 500 13 HIS A 18 22.50 -149.04 REMARK 500 13 SER A 28 67.81 -117.41 REMARK 500 13 THR A 36 38.04 -81.82 REMARK 500 REMARK 500 THIS ENTRY HAS 78 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 34069 RELATED DB: BMRB REMARK 900 SOLUTION STRUCTURE OF OXIDIZED AND AMIDATED HUMAN IAPP (1-37), THE REMARK 900 DIABETES II PEPTIDE. DBREF 5MGQ A 1 37 UNP P10997 IAPP_HUMAN 34 70 SEQRES 1 A 37 LYS CYS ASN THR ALA THR CYS ALA THR GLN ARG LEU ALA SEQRES 2 A 37 ASN PHE LEU VAL HIS SER SER ASN ASN PHE GLY ALA ILE SEQRES 3 A 37 LEU SER SER THR ASN VAL GLY SER ASN THR TYC MODRES 5MGQ TYC A 37 TYR MODIFIED RESIDUE HET TYC A 37 24 HETNAM TYC L-TYROSINAMIDE FORMUL 1 TYC C9 H12 N2 O2 HELIX 1 AA1 CYS A 7 LEU A 16 1 10 SSBOND 1 CYS A 2 CYS A 7 1555 1555 2.02 LINK C THR A 36 N TYC A 37 1555 1555 1.31 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1